NCT02504554View on ClinicalTrials.gov

Beneficial Bacteria Treatment for Autism

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Gastrointestinal ProblemsAutism Spectrum Disorders
Interventions
DRUG

oral Vancomycin

an antibiotic

DRUG

MoviPrep

a bowel cleanse

DRUG

Prilosec

a stomach acid suppressan

BIOLOGICAL

human fecal material; processed, frozen administered orally

human fecal material; processed, frozen, administered orally

BIOLOGICAL

human fecal material; processed, frozen; administered orally and rectally

human fecal material; processed, frozen; administered orally and rectally

All Listed Sponsors
collaborator

Northern Arizona University

OTHER

collaborator

University of Arizona

OTHER

collaborator

University of Minnesota

OTHER

lead

Arizona State University

OTHER

NCT02504554 - Beneficial Bacteria Treatment for Autism | Biotech Hunter | Biotech Hunter